Guiding pluripotent stem cell therapies past the immune system
Stem Cells Translational Medicine · 20.07.2026 · 15 (8)
DOI: 10.1093/stcltm/szag051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 05.08.2026. Verfasst von Hannah A Pizzato und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Molecular and Immunological Therapies, University of Arizona, Tucson, AZ 85724, United States. Hauptthemen laut MEDLINE: Pluripotent Stem Cells, Diabetes Mellitus, Type 1, Stem Cell Transplantation, Graft Rejection. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Pluripotent stem cell (PSC)-based therapies hold the potential to unlock cures for numerous diseases, including, but not limited to, Parkinson’s disease, macular degeneration, heart failure, type 1 diabetes, and cancer. Yet as protocols to differentiate PSCs into therapeutically useful cell types have progressed rapidly, immunological rejection remains a major barrier that may limit the widespread use of such PSC-based therapies. In recent years, strategies to genetically modify PSCs to prevent immunological rejection of the downstream cell product have become a point of emphasis. Here, we provide an immunological perspective on these strategies, discussing the breadth of rejection mechanisms that have been uncovered through decades of research and the relative simplicity of designing PSC immune evasion strategies to circumvent these mechanisms. We focus in particular on how these strategies apply to the treatment of type 1 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Advanced Molecular and Immunological Therapies, University of Arizona, Tucson, AZ 85724, United States.
- Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724, United States.
- Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, United States.
- BIO5 Institute, University of Arizona, Tucson, AZ 85724, United States.
- University of Arizona Cancer Center, Tucson, AZ 85724, United States.
ORCID-Profile: Hannah A Pizzato, Deepta Bhattacharya
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Pizzato, H. A., & Bhattacharya, D. (2026). Guiding pluripotent stem cell therapies past the immune system. Stem Cells Translational Medicine, 15(8). https://doi.org/10.1093/stcltm/szag051
Vancouver
Pizzato HA, Bhattacharya D. Guiding pluripotent stem cell therapies past the immune system. Stem Cells Translational Medicine. 2026;15(8). doi:10.1093/stcltm/szag051
BibTeX
@article{Pizzato2026,
author = {Pizzato, Hannah A and Bhattacharya, Deepta},
title = {Guiding pluripotent stem cell therapies past the immune system},
journal = {Stem Cells Translational Medicine},
year = {2026},
volume = {15},
number = {8},
doi = {10.1093/stcltm/szag051}
}
EUVIMED